Remacemide versus carbamazepine in newly diagnosed epilepsy
John Whitehead(Lancaster City Council), T A H Holdich(Loughborough University), Martin J. Brodie(Western Infirmary), Andrew Dean(AstraZeneca (United Kingdom)), John Stevens(Loughborough University), S. Wroe(Ipswich Hospital)
Cited by 4
Related Papers
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
A general parametric approach to the meta‐analysis of randomized clinical trials
|Statistics in Medicine|1991|765
The Design and Analysis of Sequential Clinical Trials.
|Journal of the American Statistical Association|1985|638
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry
|The Lancet Neurology|2018|537
The Design and Analysis of Sequential Clinical Trials.
|Biometrics|1997|523